Neurogene Inc.
@NeurogeneInc
Followers
594
Following
68
Statuses
208
Neurogene is focused on developing life-changing genetic medicines for patients and their families affected by rare, devastating neurological diseases.
New York, NY
Joined February 2019
Tune in today at 12:40 p.m. ET to watch our Founder and Chief Executive Officer, Rachel McMinn, in a fireside chat at the Stifel 2024 Healthcare Conference. A link to the webcast is available here:
0
0
0
Today, we reported third quarter 2024 financial results and highlighted recent updates. For full details and results, read today’s press release:
0
0
0
Today we announced positive interim efficacy data from the low-dose cohort on our ongoing Phase 1/2 trial of NGN-401 gene therapy in female pediatric patients with Rett syndrome. Join our webcast today at 4:30 p.m. ET for a review of the data. Learn more:
1
4
11
Interim clinical data from our Phase 1/2 trial of NGN-401 for Rett syndrome will be featured during a late-breaker at the 2024 @ChildNeuroSoc Annual Meeting. Join our live webcast Nov 11 at 4:30 p.m. ET for a review of the data! Learn more, visit: #CNSAM
0
0
0
Attending Cell & Gene’s 2024 Meeting on the Mesa? Don’t miss our Founder and Chief Executive Officer, Dr. Rachel McMinn, participate in a Science Slam focused on neurological disease. #CGMesa24 @alliancerm
0
1
3
Tune in today at 2:30 p.m. ET to watch our Founder and Chief Executive Officer, Dr. Rachel McMinn, in a fireside chat at the Cantor Global Healthcare Conference. A link to the webcast is available here: #CantorHCC
0
0
0
Tune in today at 11:00 a.m. ET to watch our Founder and Chief Executive Officer, Dr. Rachel McMinn, in a fireside chat at the @HCWCO 26th Annual Global Investment Conference. A link to the webcast is available here: #HCWainwrightGlobal
0
0
0
Today, we reported second quarter 2024 financial results and highlighted recent updates. For full details and results, read today’s press release:
0
0
0
We are excited to announce that the @US_FDA has granted Regenerative Medicine Advanced Therapy #RMAT designation to NGN-401 for #RettSyndrome. Learn more:
1
0
5
RT @NasdaqExchange: 🥼 Neurogene Inc is on a mission to improve the lives of patients and families devastated by rare neurological diseases.…
0
2
0
Thank you @NasdaqExchange for hosting us for an amazing morning ringing today’s opening bell! Watch the ceremony here: $NGNE #NasdaqListed
0
0
3
@tangyingch477 Thank you for your interest in Neurogene’s development program in CLN5 Batten disease. For more information, please visit or you can contact our patient advocacy team at patientadvocacy@neurogene.com.
0
0
0
On Tuesday, July 9, management will participate in the BMO 2024 Genetic Medicines Summit. Learn more:
0
0
2
@Rettsyndrome @AcadiaPharma @TayshaGTx @AnavexLifeSci We were proud to be a sponsor of such a great #RettSyndrome event!
0
0
0
Today, we joined the Russell 3000® Index as part of @FTSERussell #RussellRecon. Learn more here:
0
0
0
Tune in today at 10:40 a.m. ET to watch our Founder and Chief Executive Officer, Rachel McMinn, participate in a fireside chat at the TD Cowen Genetic Medicines & RNA Summit. A link to the webcast is available here:
0
0
1
We are pleased to share the first patient was dosed in the high-dose cohort of NGN-401 gene therapy trial for #Rettsyndrome and has been well-tolerated thus far. We'll share updated interim safety data from the low-dose cohort @Rettsyndrome ASCEND Summit.
0
0
3
Tune in today at 1:20 p.m. ET to watch our Founder and Chief Executive Officer, Rachel McMinn, present at the Goldman Sachs 45thAnnual Global Healthcare Conference. A link to the webcast is available here:
0
0
0
We had the pleasure of hosting college students at our gene therapy manufacturing facility via #NIIMBLeXperience, a program offering students from traditionally underrepresented populations the chance to gain real-world insight into biopharma. Learn more:
0
0
1
During June, Neurogene will participate in the Goldman Sachs 45th Annual Global Healthcare Conference, the 2024 IRSF Rett Syndrome Scientific Meeting, and the TD Cowen Genetic Medicines & RNA Summit. Learn more:
0
0
0